Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Insulin susp isophane recombinant human - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for insulin susp isophane recombinant human and what is the scope of insulin susp isophane recombinant human patent protection?

Insulin susp isophane recombinant human
is the generic ingredient in two branded drugs marketed by Novo Nordisk Inc and Lilly, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Insulin susp isophane recombinant human has twelve patent family members in nine countries.

There are thirty-eight drug master file entries for insulin susp isophane recombinant human. Five suppliers are listed for this compound.

Summary for Generic Name: insulin susp isophane recombinant human

Drug Master File Entries: see list38
Suppliers / Packagers: see list5
Clinical Trials: see list4,613
Drug Prices:see low prices
DailyMed Link:insulin susp isophane recombinant human at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
insulin susp isophane recombinant human
INJECTABLE;INJECTION018781-001Oct 28, 1982OTCYesYes7,291,132► SubscribeY ► Subscribe
Novo Nordisk Inc
insulin susp isophane recombinant human
INJECTABLE;INJECTION019959-001Jul 1, 1991OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus